Evening News| the first new crown oral drug was approved by the FDA, and Pfizer said it could reduce the risk of hospital death by 89%!

1. National Health Commission: 71 new local cases were added on the 22nd

At 0-24:00 on December 22, 31 provinces (autonomous regions and municipalities directly under the Central Government) and the Xinjiang Production and Construction Corps reported 100 new confirmed cases. Among them, there were 29 imported cases (11 cases in Shanghai, 8 cases in Guangdong, 3 cases in Guangxi, 2 cases in Jiangsu, 1 case in Tianjin, 1 case in Jilin, 1 case in Zhejiang, 1 case in Fujian, and 1 case in Yunnan), including 1 case from an asymptomatic infected person to a confirmed case (in Zhejiang); 71 local cases (63 cases in Shaanxi, all in Xi'an City; 4 cases in Guangxi, all in Fangchenggang City; 2 cases in Henan, all in Zhoukou City; 1 case in Zhejiang, in Shaoxing City; 1 case in Guangdong, in Dongguan City). There were no new deaths. There were no new suspected cases.

2. The second round of nucleic acid testing in Xi'an found 127 positive cases

In order to timely and effectively detect and control the source of infection and block the spread of the epidemic, Xi'an City launched the second round of nucleic acid screening for the new crown virus in the city. A total of 127 cases of nucleic acid positive personnel were found in this nucleic acid screening work, and they have been transferred to the designated medical institutions in the city for diagnosis and treatment.

3. Danish Minister of Health: The Omikejon strain has become the dominant strain in Denmark

On the 21st local time, Danish Health Minister Magnus Hoynik said through social media that the Danish National Serum Institute said that the Omikeron strain has become a new coronavirus variant strain dominated by Denmark, and the infection rate of the Omiqueron strain is still growing.

The number of new confirmed cases of new coronary pneumonia in Denmark reached 13,558 on the 21st, setting a record for the number of new confirmed cases in a single day.

4. WHO: The number of confirmed cases of COVID-19 worldwide exceeds 275.23 million

5. The first new crown oral drug was approved by the FDA, and Pfizer said it could reduce the risk of hospital death by 89%!

According to Xinhua News Agency, the US Food and Drug Administration (FDA) approved the first oral drug that can be urgently used to treat the new crown virus infection on the 22nd, for the treatment of adults with mild to moderate covid-19 and children aged 12 years and older, as well as people with a higher risk of severe illness. According to CCTV News, after review by the US Food and Drug Administration, the oral drugs produced by Pfizer are currently suitable for patients aged 12 years and above with a weight of not less than 40 kg.

Pfizer's oral drug, called Paxlovid, has been reported to block a key enzyme needed for the coronavirus to replicate, preventing the virus from replicating itself. In addition to the current trials in high-risk COVID-19 patients, Pfizer is exploring whether the drug can be used as a prophylactic drug to prevent people exposed to the virus from contracting COVID-19.

A Pfizer spokesperson said it expects to produce more than 180,000 oral doses by the end of 2021 and 50 million by the end of next year. Differential pricing is planned, with pricing in middle- and high-income countries being higher than in low-income countries, but no clear price has been given yet.